RxDoctor Payments Data

Ashley Keays

Public Health & General Preventive Medicine · Tacoma, WANPI 1346456696

Payments from drug & device makers

What this record shows

This record is dominated by other: $242,783 of the $263,679 with a category attached, or 92.1%. Neuronetics, Inc. accounts for 99.5% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2023 at $243,344 and has fallen 99.9% since, to $152 in 2025.

$263,679in general payments, 2019–2025

Across 155 payments — averaging $1701.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neuronetics, Inc.$262K
  • Johnson & Johnson$612
  • AbbVie$381
  • Teva Pharmaceuticals USA, Inc.$134
  • Pfizer$45
  • Arbor Pharmaceuticals, Inc.$43
  • plus $209 from 9 others

What the payments were for

  • Consulting fees$3,9191%
  • Speaking & faculty fees$11,3644%
  • Travel & lodging$2,3841%
  • Food & beverage$3,1461%
  • Education$840%
  • Other$242,78392%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few public health & general preventive medicine providers in Washingtonto place this figure against a meaningful peer group, so we don't.

Other public health & general preventive medicine in Tacoma

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →